Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Blood glucose criteria must be met~* Body mass index (BMI) in the range 23-45~Exclusion Criteria:~* Diagnosis of diabetes~* Serious cardiovascular events within the past 6 months~* Use of insulin or any oral antidiabetic agent~* Other protocol-defined exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).